Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136159 · ClinicalTrials.gov registry record · NA
The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications
A NA study of Cesarean Section; Complications, Wound, Dehiscence, sponsored by Loyola University.
- Completed
- Registry status
- NA
- Development phase
- 380
- Enrollment target
- 1
- Study location
NCT03136159: Completed NA study of Cesarean Section; Complications, Wound, Dehiscence, sponsored by Loyola University.
NCT03136159 is a NA study of Cesarean Section; Complications, Wound, Dehiscence that has completed, run by Loyola University. The registered enrollment target is 380 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03136159, a NA study of Cesarean Section; Complications, Wound, Dehiscence, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
- 1
- Study location
Study Summary
Post-cesarean section wound infections are responsible for longer hospital stays, readmissions, and ultimately, increased costs to the healthcare system. Silver-containing dressings may prevent wound infections. The purpose of the current study is to determine if the use of a silver-impregnated dressing decreases the occurence of wound infection following cesarean delivery.
Primary Outcome
Rate of wound disruption and /or infection occurring by 6 weeks was compared to a historical control rate of 10%, and to a contemporary group who received a standard dressing
Conditions Studied
Interventions
- DEVICE Silver-impregnated antimicrobial dressing
Study Locations (1)
Illinois
- Loyola University Medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT03136159 record still lists
NCT03136159 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Cesarean Section; Complications, Wound, Dehiscence appearing as the primary indexed condition, and to 1 intervention - of which Silver-impregnated antimicrobial dressing is the first listed.
NCT03136159 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03136159 about?
NCT03136159 is a clinical study titled "The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications". Post-cesarean section wound infections are responsible for longer hospital stays, readmissions, and ultimately, increased costs to the healthcare system. Silver-containing dressings may prevent wound infections. The purpose of the current study is to determine if the use of a silver-impregnated dres...
What is the current status of trial NCT03136159?
This trial is currently completed. It is a NA study. The enrollment target is 380 participants. The study started on 2017-07-24. Estimated completion is 2019-06-30.
What conditions does trial NCT03136159 study?
This clinical trial studies the following conditions: Cesarean Section; Complications, Wound, Dehiscence.
What interventions are being tested in trial NCT03136159?
The interventions under investigation include: Silver-impregnated antimicrobial dressing (DEVICE).
Who is sponsoring clinical trial NCT03136159?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136159 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03136159's enrollment target sits among peer trials
380 273rd of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI